Flichy-Fernández AJ, González-Lemonnier S, Balaguer-Martínez J, Peñarrocha-Oltra D, Peñarrocha-Diago MA, Bagán-Sebastián JV. Bone necrosis around dental implants: a patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX. J Clin Exp Dent. 2012;4(1):e82-5.

doi:10.4317/jced.4.50698

http://dx.doi.org/doi:10.4317/jced.4.50698

 

References

1. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg. 2009;67:2-12.

http://dx.doi.org/10.1016/j.joms.2009.01.009

PMid:19371809

 

2. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397-410.

http://dx.doi.org/10.1016/j.joms.2007.08.003

PMid:18022461

 

3. Grant B, Amenedo C, Freeman K, Kraut RA. Outcomes of placement dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg 2008;66:223-30.

http://dx.doi.org/10.1016/j.joms.2007.09.019

PMid:18201600

 

4. Bagán JV, Jiménez Y, Gómez D, Sirera R, Poveda R, Scully C. Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates. Oral Oncol 2008;44:1088-9.

http://dx.doi.org/10.1016/j.oraloncology.2008.01.012

PMid:18396443

 

5. Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res 2009;20;4:87-95.

http://dx.doi.org/10.1111/j.1600-0501.2009.01772.x

PMid:19663954

 

6. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. J Periodontol. 2007;78:584-94.

http://dx.doi.org/10.1902/jop.2007.060239

PMid:17335384

 

7. Kunchur R, Need A, Hughes T, Goss A. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:1167-73.

http://dx.doi.org/10.1016/j.joms.2009.02.004

PMid:19446200

 

8. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:433-41.

http://dx.doi.org/10.1016/j.tripleo.2006.06.004

PMid:16997108